title: Should routine screening for coeliac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C?
authors.forename: Giovanni
authors.initials: G
authors.lastname: Casella
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Bardella
authors.forename: Daniele
authors.initials: D
authors.lastname: Perego
authors.forename: Vittorio
authors.initials: V
authors.lastname: Baldini
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002446:Celiac Disease / Q000175:diagnosis*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons